This suggests that interventions targeting Piezo1 in cancer therapy may simultaneously impact both the TME and the surrounding normal tissues (Jiang et al., 2022; Qu and Zhang, 2025; Zhu Z. et al., 2022). Here, PIEZO1 is linked to cancer.